E Tsourdi1, H Wallaschofski2,3, M Rauner1, M Nauck2, M Pietzner2, R Rettig4, T Ittermann5, H Völzke5, U Völker6, L C Hofbauer7,8, A Hannemann2. 1. Department of Medicine III, Technische Universität Dresden, Dresden, Germany. 2. Institute of Clinical Chemistry and Laboratory Medicine, University Medicine Greifswald, Greifswald, Germany. 3. Schwerpunktpraxis für Diabetes und Hormonerkrankungen, Erfurt, Germany. 4. Institute of Physiology, University Medicine Greifswald, Greifswald, Karlsburg, Germany. 5. Institute for Community Medicine, University Medicine Greifswald, Greifswald, Germany. 6. Functional Genomics Laboratory, University Medicine Greifswald, Greifswald, Germany. 7. Department of Medicine III, Technische Universität Dresden, Dresden, Germany. lorenz.hofbauer@uniklinikum-dresden.de. 8. Center for Regenerative Therapies Dresden, Technische Universität Dresden, Dresden, Germany. lorenz.hofbauer@uniklinikum-dresden.de.
Abstract
UNLABELLED: In two large German population-based cohorts, we showed positive associations between serum thyrotropin (TSH) concentrations and the Fracture Risk Assessment score (FRAX) in men and positive associations between TSH concentrations and bone turnover markers in women. INTRODUCTION: The role of thyroid hormones on bone stiffness and turnover is poorly defined. Existing studies are confounded by differences in design and small sample size. We assessed the association between TSH serum concentrations and bone stiffness and turnover in the SHIP cohorts, which are two population-based cohorts from a region in Northern Germany comprising 2654 men and women and 3261 men and women, respectively. METHODS: We calculated the bone stiffness index using quantitative ultrasound (QUS) at the calcaneus, employed FRAX score for assessment of major osteoporotic fractures, and measured bone turnover markers, N-terminal propeptide of type I procollagen (P1NP), bone-specific alkaline phosphatase (BAP), osteocalcin, and type I collagen cross-linked C-telopeptide (CTX) in all subjects and sclerostin in a representative subgroup. RESULTS: There was no association between TSH concentrations and the stiffness index in both genders. In men, TSH correlated positively with the FRAX score both over the whole TSH range (p < 0.01) and within the reference TSH range (p < 0.01). There were positive associations between TSH concentrations and P1NP, BAP, osteocalcin, and CTX (p < 0.01) in women but not in men. There was no significant association between TSH and sclerostin levels. CONCLUSIONS: TSH serum concentrations are associated with gender-specific changes in bone turnover and stiffness.
UNLABELLED: In two large German population-based cohorts, we showed positive associations between serum thyrotropin (TSH) concentrations and the Fracture Risk Assessment score (FRAX) in men and positive associations between TSH concentrations and bone turnover markers in women. INTRODUCTION: The role of thyroid hormones on bone stiffness and turnover is poorly defined. Existing studies are confounded by differences in design and small sample size. We assessed the association between TSH serum concentrations and bone stiffness and turnover in the SHIP cohorts, which are two population-based cohorts from a region in Northern Germany comprising 2654 men and women and 3261 men and women, respectively. METHODS: We calculated the bone stiffness index using quantitative ultrasound (QUS) at the calcaneus, employed FRAX score for assessment of major osteoporotic fractures, and measured bone turnover markers, N-terminal propeptide of type I procollagen (P1NP), bone-specific alkaline phosphatase (BAP), osteocalcin, and type I collagen cross-linked C-telopeptide (CTX) in all subjects and sclerostin in a representative subgroup. RESULTS: There was no association between TSH concentrations and the stiffness index in both genders. In men, TSH correlated positively with the FRAX score both over the whole TSH range (p < 0.01) and within the reference TSH range (p < 0.01). There were positive associations between TSH concentrations and P1NP, BAP, osteocalcin, and CTX (p < 0.01) in women but not in men. There was no significant association between TSH and sclerostin levels. CONCLUSIONS:TSH serum concentrations are associated with gender-specific changes in bone turnover and stiffness.
Entities:
Keywords:
Bone remodeling; Bone stiffness; Sclerostin; Thyroid hormones
Authors: S L Greenspan; M L Bouxsein; M E Melton; A H Kolodny; J H Clair; P T Delucca; M Stek; K G Faulkner; E S Orwoll Journal: J Bone Miner Res Date: 1997-08 Impact factor: 6.741
Authors: Henry Völzke; Dietrich Alte; Carsten Oliver Schmidt; Dörte Radke; Roberto Lorbeer; Nele Friedrich; Nicole Aumann; Katharina Lau; Michael Piontek; Gabriele Born; Christoph Havemann; Till Ittermann; Sabine Schipf; Robin Haring; Sebastian E Baumeister; Henri Wallaschofski; Matthias Nauck; Stephanie Frick; Andreas Arnold; Michael Jünger; Julia Mayerle; Matthias Kraft; Markus M Lerch; Marcus Dörr; Thorsten Reffelmann; Klaus Empen; Stephan B Felix; Anne Obst; Beate Koch; Sven Gläser; Ralf Ewert; Ingo Fietze; Thomas Penzel; Martina Dören; Wolfgang Rathmann; Johannes Haerting; Mario Hannemann; Jürgen Röpcke; Ulf Schminke; Clemens Jürgens; Frank Tost; Rainer Rettig; Jan A Kors; Saskia Ungerer; Katrin Hegenscheid; Jens-Peter Kühn; Julia Kühn; Norbert Hosten; Ralf Puls; Jörg Henke; Oliver Gloger; Alexander Teumer; Georg Homuth; Uwe Völker; Christian Schwahn; Birte Holtfreter; Ines Polzer; Thomas Kohlmann; Hans J Grabe; Dieter Rosskopf; Heyo K Kroemer; Thomas Kocher; Reiner Biffar; Ulrich John; Wolfgang Hoffmann Journal: Int J Epidemiol Date: 2010-02-18 Impact factor: 7.196
Authors: Sun Wook Cho; Jae Hyun Bae; Gyeong Woon Noh; Ye An Kim; Min Kyong Moon; Kyoung Un Park; Junghan Song; Ka Hee Yi; Do Joon Park; June-Key Chung; Bo Youn Cho; Young Joo Park Journal: PLoS One Date: 2015-12-09 Impact factor: 3.240
Authors: Anne T Nies; Stefan Weiss; Elke Schaeffeler; Anke Hannemann; Uwe Völker; Henri Wallaschofski; Matthias Schwab Journal: Front Endocrinol (Lausanne) Date: 2020-08-18 Impact factor: 5.555